ResearchHub Logo
Currency
Display format
RSCUSD

Inflammatory Biomarkers Predict Response and Survival in Chemotherapy-Ineligible and Untreated Acute Myeloid Leukemia Patients Receiving Venetoclax-Azacytidine As Front-Line Therapy

Authors
Mathilde BastienMaxime JullienPatrice Chevallier
Journal
Blood
Published
November 5, 2024
Sign in to review
Share your thoughts on this paper...

No reviews yet.

Be the first to review this paper.

Supporters

Support the authors with ResearchCoin

Topics

DOI

10.1182/blood-2024-201589

License

Unknown License
Inflammatory Biomarkers Predict Response and Survival in ... | ResearchHub